Blueprint Genetics raised €14M in a Series A round in Aug 2017. The company is based in Helsinki, Finland. Investors in the round: Creathor Venture, Inventure Oy, MedTech Innovation Partners and 2 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €14M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
